Lipocine (LPCN) Asset Utilization Ratio (2018 - 2025)
Lipocine (LPCN) has disclosed Asset Utilization Ratio for 10 consecutive years, with 0.25 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Asset Utilization Ratio fell 26.08% year-over-year to 0.25, compared with a TTM value of 0.25 through Sep 2025, down 26.08%, and an annual FY2024 reading of 0.49, up 422.55% over the prior year.
- Asset Utilization Ratio was 0.25 for Q3 2025 at Lipocine, up from 0.22 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.52 in Q4 2024 and bottomed at 0.01 in Q1 2021.
- Average Asset Utilization Ratio over 5 years is 0.21, with a median of 0.22 recorded in 2025.
- The sharpest move saw Asset Utilization Ratio crashed 502.57% in 2021, then soared 25312.93% in 2024.
- Year by year, Asset Utilization Ratio stood at 0.34 in 2021, then tumbled by 96.23% to 0.01 in 2022, then skyrocketed by 818.97% to 0.12 in 2023, then soared by 334.12% to 0.52 in 2024, then plummeted by 51.86% to 0.25 in 2025.
- Business Quant data shows Asset Utilization Ratio for LPCN at 0.25 in Q3 2025, 0.22 in Q2 2025, and 0.17 in Q1 2025.